[{"Assets_0_Q2_USD":289722557.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-194810.0,"NetIncomeLoss_1_Q2_USD":634660.0,"NetIncomeLoss_2_Q2_USD":634539.0,"StockholdersEquity_0_Q2_USD":5000001.0,"Ticker":"CELU","CIK":"1752828","name":"GX ACQUISITION CORP.","OfficialName":"Celularity Inc. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1622347796.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]